George Zhang

Edoxaban for the Treatment of Cancer-Associated Venous Thromboembolism

Gary E. Raskob, Nick van Es, Peter Verhamme et al. · New England Journal of Medicine · 2017 · 1.6K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Drug-Drug Interaction Studies of Cardiovascular Drugs Involving P-Glycoprotein, an Efflux Transporter, on the Pharmacokinetics of Edoxaban, an Oral Factor Xa Inhibitor

Jeanne Mendell, Hamim Zahir, Nobuko Matsushima et al. · American Journal of Cardiovascular Drugs · 2013 · 223 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Clinical Impact of Bleeding in Cancer-Associated Venous Thromboembolism: Results from the Hokusai VTE Cancer Study

Noémie Kraaijpoel, Marcello Di Nisio, Frits I. Mulder et al. · Thrombosis and Haemostasis · 2018 · 214 citations · Full text

Medicine, Hematology, Oncology +17

Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells

Hong Jiang, George Zhang, Feng Dong et al. · Journal of Biological Chemistry · 2002 · 157 citations · Full text

Life Sciences, Cell Biology, Oncology +15

Edoxaban for venous thromboembolism in patients with cancer: results from a non-inferiority subgroup analysis of the Hokusai-VTE randomised, double-blind, double-dummy trial

Gary E. Raskob, Nick van Es, Annelise Segers et al. · The Lancet Haematology · 2016 · 155 citations

Medicine, Oncology, Pharmacotherapy +13